DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS)
CNY 17.05
(-1.56%)
CNY 17.05
(-1.56%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 24.43 Billion CNY | 15.01% |
| 2022 | 21.24 Billion CNY | 26.78% |
| 2021 | 16.75 Billion CNY | 14.92% |
| 2020 | 14.58 Billion CNY | 30.89% |
| 2019 | 11.14 Billion CNY | 25.76% |
| 2018 | 8.85 Billion CNY | 19.38% |
| 2017 | 7.42 Billion CNY | 18.29% |
| 2016 | 6.27 Billion CNY | 19.15% |
| 2015 | 5.26 Billion CNY | 15.85% |
| 2014 | 4.54 Billion CNY | 22.62% |
| 2013 | 3.7 Billion CNY | 13.96% |
| 2012 | 3.25 Billion CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 6.56 Billion CNY | -2.42% |
| 2024 Q1 | 6.72 Billion CNY | -0.67% |
| 2024 Q3 | 6.35 Billion CNY | -3.15% |
| 2023 Q4 | 6.77 Billion CNY | 18.19% |
| 2023 Q1 | 5.94 Billion CNY | -7.52% |
| 2023 Q2 | 6.04 Billion CNY | 1.65% |
| 2023 FY | 24.43 Billion CNY | 15.01% |
| 2023 Q3 | 5.73 Billion CNY | -5.19% |
| 2022 Q2 | 5.04 Billion CNY | 7.84% |
| 2022 FY | 21.24 Billion CNY | 26.78% |
| 2022 Q4 | 6.43 Billion CNY | 26.16% |
| 2022 Q3 | 5.09 Billion CNY | 1.06% |
| 2022 Q1 | 4.67 Billion CNY | 6.19% |
| 2021 Q1 | 4.05 Billion CNY | -0.77% |
| 2021 Q3 | 4.3 Billion CNY | 7.63% |
| 2021 FY | 16.75 Billion CNY | 14.92% |
| 2021 Q2 | 3.99 Billion CNY | -1.56% |
| 2021 Q4 | 4.4 Billion CNY | 2.41% |
| 2020 Q3 | 3.55 Billion CNY | -0.73% |
| 2020 Q2 | 3.57 Billion CNY | 6.42% |
| 2020 FY | 14.58 Billion CNY | 30.89% |
| 2020 Q1 | 3.36 Billion CNY | 8.44% |
| 2020 Q4 | 4.09 Billion CNY | 15.17% |
| 2019 FY | 11.14 Billion CNY | 25.76% |
| 2019 Q3 | 2.78 Billion CNY | 4.27% |
| 2019 Q4 | 3.1 Billion CNY | 11.2% |
| 2019 Q1 | 2.57 Billion CNY | 0.71% |
| 2019 Q2 | 2.67 Billion CNY | 3.7% |
| 2018 Q1 | 2.03 Billion CNY | -4.14% |
| 2018 Q4 | 2.56 Billion CNY | 15.53% |
| 2018 FY | 8.85 Billion CNY | 19.38% |
| 2018 Q2 | 2.04 Billion CNY | 0.73% |
| 2018 Q3 | 2.21 Billion CNY | 8.16% |
| 2017 Q3 | 1.79 Billion CNY | 1.91% |
| 2017 Q1 | 1.73 Billion CNY | 2.62% |
| 2017 Q2 | 1.76 Billion CNY | 1.59% |
| 2017 FY | 7.42 Billion CNY | 18.29% |
| 2017 Q4 | 2.12 Billion CNY | 18.0% |
| 2016 Q2 | 1.48 Billion CNY | 1.28% |
| 2016 Q1 | 1.46 Billion CNY | 0.0% |
| 2016 Q3 | 1.63 Billion CNY | 9.81% |
| 2016 Q4 | 1.69 Billion CNY | 3.8% |
| 2016 FY | 6.27 Billion CNY | 19.15% |
| 2015 Q1 | 1.26 Billion CNY | 0.0% |
| 2015 Q2 | 1.26 Billion CNY | 0.0% |
| 2015 FY | 5.26 Billion CNY | 15.85% |
| 2014 FY | 4.54 Billion CNY | 22.62% |
| 2013 FY | 3.7 Billion CNY | 13.96% |
| 2012 FY | 3.25 Billion CNY | 0.0% |